LY3143921 hydrate is an orally administered ATP-competitive CDC7 inhibitor.
[1] Peter F. Gallagher, et al. Journal of Clinical Oncology. Volume 37, Issue 15_suppl.
| 规格 | 价格 | 库存 | 数量 | 操作 |
|---|---|---|---|---|
| 5mg | ¥1,886.00 | 现货 | 1 | |
| 25mg | ¥5,658.00 | 现货 | 1 |
















LY3143921 hydrate is an orally administered ATP-competitive CDC7 inhibitor.
[1] Peter F. Gallagher, et al. Journal of Clinical Oncology. Volume 37, Issue 15_suppl.